Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI).
J Clin Med
; 11(8)2022 Apr 14.
Article
in En
| MEDLINE
| ID: mdl-35456280
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
J Clin Med
Year:
2022
Document type:
Article
Affiliation country:
España
Country of publication:
Suiza